S. Margaret Paik to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications S. Margaret Paik has written about In Situ Hybridization, Fluorescence.
Connection Strength
0.060
-
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2. J Clin Oncol. 2020 02 10; 38(5):444-453.
Score: 0.036
-
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. Arch Pathol Lab Med. 2014 Feb; 138(2):241-56.
Score: 0.024